Sleep difficulties after blood-derived cell treatment

This is a historical account of the original author’s experiences and interpretations. Research claims, numerical results, mechanisms and legal descriptions remain pending comparison with primary sources and hospital medical review. They do not establish a treatment benefit or current applicability.

Editorial note: flu-like symptoms or insomnia do not prove recovery or successful cell activity. New symptoms after a procedure require clinical assessment; severe symptoms such as shortness of breath or chest pain need urgent medical attention.

After blood-derived cell treatment, I felt tired but could not fall asleep easily. This was my third treatment and, in my own experience, I stayed awake on the treatment night each time, despite normally feeling sleepy around midnight. I found it puzzling and began reading and writing about possible explanations. This is a personal temporal association, not proof of the cause.

1. A proposed connection with sympathetic activity

The original author interpreted the experience as a physiological transition involving cells, immune and circulatory rhythms, nerves and hormones. The post proposed that infused hematopoietic stem cells (HSCs), sympathetic activity and norepinephrine could relate to cellular movement or homing while also affecting arousal.

It cited a 2025 paper attributed to Moradi and colleagues in Stem Cell Research & Therapy for a two-way relationship between circadian disruption, sleep and stem-cell self-renewal. The original inference that cell activation itself caused transient insomnia has not been established here; the precise paper and the claimed interpretation require verification.

2. Sleep in hematopoietic stem-cell transplant patients

The post attributed a 2021 study at King Hussein Cancer Center in Jordan to Abdalrahman and colleagues. It reported 163 transplant patients, clinical insomnia in 48.5% within 30 days, and an average Insomnia Severity Index (ISI) of 14.06 ± 7.71. It interpreted this as a period of immune reconstitution involving blood-cell production and changes in temperature, hormones and inflammatory cytokines.

These figures and the source interpretation remain pending comparison with the original paper. A transplant population cannot simply be treated as equivalent to people receiving other blood-derived procedures.

3. Inflammation and sleep: the proposed explanation

The author proposed that IL-6 and TNF-α might affect hypothalamic temperature and sleep pathways, producing slightly higher temperature, shallower sleep or repeated awakenings. The post also said that patients receiving radiotherapy in the cited study had higher insomnia scores. That account does not establish that inflammation or stem-cell homing caused this author's insomnia.

4. The reported time course

The source reported that around 60 days after transplantation, insomnia scores tended to fall, giving an ISI of 8.56 ± 4.78 after 60 days. It interpreted this as stabilization of immune and inflammatory activity and suggested that insomnia could resolve with recovery. The author also recalled acquaintances saying that their sleep was deeper about a month after treatment.

The study figures, the proposed mechanism and the personal observations are distinct types of information. None guarantees when an individual person's sleep will recover.

5. Sleep and cell rhythms

The original essay described sleep as a regulator of cellular biological clocks. It proposed roles for melatonin and growth hormone in DNA repair and stated that inadequate sleep could impair differentiation and self-renewal. It then interpreted insomnia after treatment as cells finding a new rhythm. That final interpretation remains the author's hypothesis.

Original conclusion

The author described treatment-night wakefulness as a temporary resetting of biological rhythms involving sympathetic activity, inflammatory cytokines and immune signals, using the metaphor of ‘a night when cells are awake.’ This metaphor and proposed mechanism do not diagnose the cause of insomnia or establish that it is beneficial.

The original post stated that it was intended to share medical information rather than promote a particular procedure, product or clinic.